InvestorsHub Logo

kris_kade

12/01/16 10:00 AM

#203 RE: tste9 #202

No negative results. Simply not much of catalysts. Big one is PR if successful launch of Entyce Q1'17

However they can always announce additional partnership anytime ! Either expand Elanco deal or enter into new one with another big AHC pharma